Recnac Oncology Private Limited, a active private limited company, was established on 19 November 2018 in Chennai, Tamil Nadu, India. Engaging in oncology clinics & cancer treatment within the hospital and medical care sector, it holds CIN: U93000TN2018PTC125864. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
Its leadership includes Mahalingam Sivakumar (Additional Director), Ganesamoni Sivaram (Additional Director), Ramani Balaji (Director). Past directors included Duraisamy Sriprakash. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Old No.5/5, New No.9/5, Gopalakrishna Road, Chennai, Tamil Nadu, 600017.
U93000TN2018PTC125864
125864
19 November 2018
₹1.00 M
₹0.50 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Recnac Oncology Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mahalingam Sivakumar | Additional Director | 23 Nov 2018 | Current |
| Ganesamoni Sivaram | Additional Director | 23 Nov 2018 | Current |
| Ramani Balaji | Director | 19 Nov 2018 | Current |
| Dhanasekar Padmanabhan | Director | 19 Nov 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 27 Mar 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Recnac Oncology Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 94.75% increase. The company also saw a substantial improvement in profitability, with a 321.58% increase in profit. The company's net worth Soared by an impressive increase of 62.15%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Recnac Oncology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Recnac Oncology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Recnac Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Recnac Oncology's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Recnac Oncology Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Recnac Oncology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was completed.
Mahalingam Sivakumar was appointed as a Additional Director was appointed as a Additional Director on 23 Nov 2018 & has been associated with this company since 7 years 7 days . was recorded as a recent event.
Progress on Ganesamoni Sivaram was appointed as a Additional Director was appointed as a Additional Director on 23 Nov 2018 & has been associated with this company since 7 years 7 days . was documented.
The activity Ramani Balaji was appointed as a Director was appointed as a Director on 19 Nov 2018 & has been associated with this company since 7 years 11 days . was completed.
Progress on Dhanasekar Padmanabhan was appointed as a Director was appointed as a Director on 19 Nov 2018 & has been associated with this company since 7 years 11 days . was documented.
The CIN of Recnac Oncology Private Limited is U93000TN2018PTC125864.
Recnac Oncology Private Limited is headquartered at Old No.5/5, New No.9/5, Gopalakrishna Road, Chennai, Tamil Nadu, 600017.
Recnac Oncology Private Limited was incorporated on 19 November 2018.
The current directors of Recnac Oncology Private Limited are
The primary industry of Recnac Oncology Private Limited is Hospital And Medical Care.
Recnac Oncology Private Limited is unlisted.
The authorized capital of Recnac Oncology Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX